In many kidney diseases, the original insult primarily involves the glomerulus and may then pass onto the tubulointerstitium. Several hypotheses link glomerular disease to tubular injury; perhaps the foremost hypothesis involves chronic tubular hypoxia. The reported effects of hypoxia and consecutive stabilization of hypoxiainducible factors (HIFs), however, are controversial. Hypoxia induces interstitial fibrosis but also has beneficial effects on renal disease progression when HIF is activated pharmacologically. To analyze the impact of HIF on tubulointerstitial disease development in primary glomerular disease, transgenic von Hippel Lindau (VHL)-knockout mice were generated and null expression was induced before the onset of autoimmune IgG-mediated anti-glomerular basement membrane glomerulonephritis (GN). Tubular VHL knockout and, thus, local HIF-␣ stabilization increased renal production of vascular endothelial growth factor, tumor growth factor-␤ 1 , and platelet-derived growth factor-B, resulting in augmented formation of capillaries and interstitial matrix, and conversion of fibroblasts to myofibroblasts. Within the glomerular disease, VHL knockout reduced the glomerular damage and attenuated tubulointerstitial injury. Likewise, proteinuria, plasma urea concentration, and tubulointerstitial matrix were decreased in VHL knockout with GN. These findings shown that tubular HIF-␣ stabilization in glomerular disease is beneficial for disease outcome. In comparison with VHL knockout alone, GN is a much stronger activator of fibrosis such that stimuli other than hypoxia may be considered important for renal disease progression.
Many forms of acute glomerulonephritis (GN) tend to progress to chronic GN, which is characterized by irreversible, progressive glomerular and tubulointerstitial fibrosis. The insult involves primarily the glomerulus and then may be transferred to the tubulointerstitium, but the relationship between glomerular damage and tubular injury remains incompletely understood. [1] [2] [3] There are several hypotheses linking primary glomerular disease to tubular injury; perhaps the foremost involves the occurrence of tubular hypoxia. 4, 5 Renal hypoxia may result from a combination of structural and functional changes. Structural alterations include capillary rarefaction; compromised peritubular blood flow resulting from glomerular injury, which may involve the efferent arterioles and affect the blood supply for the tubule; and limited oxygen diffusion as a consequence of extracellular matrix expansion. Functional changes comprise vasoconstriction from altered levels of vasoactive factors and signaling molecules, increased oxygen demand from hyperfiltration and tubular hypertrophy, and renal anemia. 4, 6, 7 Hypoxic conditions lead to stabilization of hypoxiainducible factors (HIF) belonging to the Per-ARNT-Sim family of basic helix-loop-helix transcription factors and consisting of an oxygen-sensitive ␣-subunit and a constitutively expressed ␤-subunit. 8 Under conditions of normal oxygen tension HIF is hydroxylated and rapidly degraded by proteasomal inactivation. von Hippel-Lindau (VHL) is a component of the E3 ubiquitin ligase that targets proteins for degradation in the proteasome. Loss
The effects of hypoxia and HIF-␣ induction on the progression of a renal disease, however, are discussed controversially. Renal HIF-1␣ expression correlates with the degree of tissue injury and fibrosis, 9 suggesting a relevance to the development and progression of kidney diseases. Conversely, activation of HIF has been shown to ameliorate disease development in antiThy1 GN, 10 remnant kidney model, 11 and in a model of diabetic nephropathy. 12 To analyze the impact of tubular HIF-␣ induction in the setting of a transfer from a primary glomerular disease onto the tubulointerstitium, a preventive strategy was chosen. Therefore, a tetracycline-inducible VHL-knockout mouse model was generated and induced before the onset of a rapid progressive GN. VHL knockout resulted in augmented interstitial capillary proliferation and marginal matrix production. However, anti-glomerular basement membrane (GBM) GN was significantly less developed in VHL knockout mediated through diminished glomerular disease development. In this context, the beneficial effects of tubular HIF-␣ stabilization clearly overbalanced the harmful increase in interstitial matrix, leading to attenuation in disease progression.
Materials and Methods

Transgenic Animals
A conditional transgenic system was used to disrupt VHL expression within the renal tubular system of adult mice. Three transgenic mouse lines were cross-bred: i) Pax8 -reverse tetracycline-dependent transactivator mice, which express the reverse tetracycline-dependent transactivator under control of the Pax8 promoter (expressed along the tubular system and periportal hepatocytes with an efficiency of ϳ65%), 13 ii) LC-1 mice, which express Cre recombinase under the control of the bidirectional P tet promoter, 14 and iii) VHL flox/flox mice for targeted disruption of VHL. 15 All mice were genotyped by PCR analysis of tail DNA for Pax8 -reverse tetracycline-dependent transactivator, LC-1, and VHL flox/flox .
Experimental Design
A total of 32 3-month-old male mice from several litters were used and divided into four groups. For the induction of the VHL knockout, mice (n ϭ 16) received 0.2 mg/mL doxycycline/5% glucose in the drinking water for 2 days. The control mice (n ϭ 16) received only 5% glucose in the drinking water. Initiation of VHL knockout was performed 3 days before the anti-GBM administration. For the induction of the anti-GBM GN all mice were primed immunologically by subcutaneous injection of rabbit IgG in complete Freund's adjuvant. GN was induced 6 days later by the intravenous injection of a rabbit anti-mouse GBM serum 16 (n ϭ 20), whereas the control mice (n ϭ 12) received an injection of vehicle (0.9% NaCl). All mice were sacrificed after 18 days of anti-GBM GN treatment.
Group specification was as follows: group 1 (ϪDOX; n ϭ 6) received vehicle injection; group 2 (ϩDOX; n ϭ 6) received 0.2 mg/mL doxycycline and vehicle injection; group 3 (ϪDOX/GN; n ϭ 10) received injection of rabbit anti-GBM serum; and group 4 (ϩDOX/GN; n ϭ 10) received 0.2 mg/mL doxycycline and injection of anti-GBM serum. The experimental design of this study was approved by the local authorities according to the German and Swiss laws for protection of animals (registered under G 0178/03 and Fr 51/10).
Before the experiment and then once a week afterward, ϳ200 L of blood was collected by puncture of the submandibular vein from each animal under isoflurane anesthesia. Hemoglobin concentration was determined by ABL800 FLEX (Radiometer, Willich, Germany). Plasma urea nitrogen was quantified enzymatically using routine automated methods (Modular Analytics; Roche Diagnostics, Mannheim, Germany). Plasma vascular endothelial growth factor (VEGF) levels were determined by a commercial enzyme-linked immunosorbent assay (Raybiotech, Heidelberg, Germany). For urinary protein analysis, mice were placed individually in metabolic cages for 24 hours and urine protein concentration was measured with a standardized autoanalyzer (Hitachi 747; Roche Diagnostics).
Detection of Circulating Anti-Rabbit IgG
For the detection of circulating anti-rabbit IgG, microtiter plates were coated with 100 g/mL rabbit IgG (Jackson Laboratories, West Grove, PA) followed by blocking with 5% skim milk and incubation with mouse serum obtained from each animal at the end of the experiment. After the incubation with horseradish-peroxidase-conjugated goat anti-mouse IgG (Abcam, Cambridge, UK) the signal was generated using 3,3=,5,5=-tetramethylbenzidine (Sigma Aldrich, München, Germany) and measured at 450 nm.
Perfusion, Fixation, and Tissue Processing
Mice were anesthetized by an intraperitoneal injection of sodium pentobarbital (0.06 mg/g body weight). After laparotomy, one kidney was clamped, removed, and shockfrozen for biochemical analysis and the other kidney then was perfused in vivo via the abdominal aorta using 3% paraformaldehyde. For cryostat sectioning, tissues were shock-frozen and stored at Ϫ80°C. Alternatively, tissues were postfixed in 3% paraformaldehyde, dehydrated, and standard paraffin-embedded. For ultrastructural analysis, kidney specimens were postfixed in 1.5% paraformaldehyde/PBS containing 1.5% glutaraldehyde, and 0.05% picric acid, rinsed, and stored in PBS until embedding in Epon (Serva, Heidelberg, Germany). Ultrathin sections were viewed in a Zeiss EM 906 electron microscope (Zeiss, Oberkochen, Germany).
RNA Isolation, Reverse Transcription, and RealTime PCR
Total RNA was extracted from kidney homogenates using the RNeasy Mini kit (Qiagen, Hilden, Germany). Genomic DNA was digested by DNase I (Invitrogen, Carlsbad, CA), and cDNA was synthesized by reverse transcription of 5 g of total RNA (SuperScript First-Strand Synthesis System; Invitrogen). TaqMan Gene Expression Assays were used, and the product IDs were as follows: erythropoietin, Mm01202755_m1; VEGF-A, Mm00437306_m1; tumor growth factor-␤ 1 (TGF-␤ 1 ), Mm03024053_m1; and plateletderived growth factor-B (PDGF-B), Mm01298578_m1. The experiments were performed according to the manual provided by Applied Biosystems (Foster City, CA). Amplifications were performed using the real-time PCR TaqMan Fast 7500 (Applied Biosystems). Threshold cycle values were set in the linear phase of exponential amplification. The difference (⌬ threshold cycle) between values obtained for erythropoietin, VEGF, TGF-␤ 1 , PDGF-B, and the housekeeping genes 28S ribosomal RNA Mm03682676_s1 and TATA-box binding protein Mm00446973_m1 were calculated and the mRNA abundance of all four groups is presented in percentages.
In Situ Hybridization
The mRNA expression of TGF-␤ 1 and osteopontin was investigated by in situ hybridization using digoxigeninlabeled riboprobes (Roche). Sense and antisense probes were generated by in vitro transcription of a 700-bp TGF-␤ 1 cDNA and a 1100-bp osteopontin cDNA template. In situ hybridization was performed on 5-m-thick paraffin sections according to an established protocol. 17 Signal was generated with 4-nitroblue tetrazolium chloride. For control, sense probes were applied in parallel with antisense probes.
Immunohistochemistry
Immunohistochemistry for VHL, HIF-1␣, HIF-2␣, and heme oxygenase-1 (HO-1) was performed on 4-m-thick paraffin sections using the Catalyzed Signal Amplification System (Dako, Baar, Switzerland). VEGF immunostaining was performed with the Vectastain ABC kit (Vector, Burlingame, CA). Immunohistochemistry using fluorescencecoupled secondary antibodies was used for all other immunodetections. The following antibodies were used: polyclonal rabbit anti-VHL (Labforce, Nunningen, Switzerland), polyclonal rabbit anti-HIF1␣ (Cayman Chemicals, Ann Arbor, MI), polyclonal rabbit anti-HIF2␣ (PM9 kindly provided by Patrick Maxwell), polyclonal goat anti-VEGF antibody (R&D Systems, Minneapolis, MN), polyclonal rabbit anti-rat type I collagen antibody (Biotrend, Köln, Germany), polyclonal rabbit anti-Wilms tumor-1 antibody (Santa Cruz Biotechnology, Heidelberg, Germany), monoclonal rat anti-Ki-67 antibody (Dako), rabbit anti-5=ectonucleotidase (kind gift from Johannes Loffing), polyclonal rabbit anticaveolin (Santa Cruz Biotechnology), polyclonal rabbit anti-TGF-␤ 1 (Acris, Herford, Germany), rabbit anti-␣-smooth muscle actin (␣-SMA; Abcam), and rabbit anti-HO-1 (Acris). For all antibodies, negative controls were used in which the primary antibody was omitted. For double-labeling, primary antibodies were administered consecutively. Light microscopy specimens were evaluated using a Leica DMRB fluorescence microscope (Leica Microsystems, Heerbrugg, Switzerland) equipped with a digitized camera system and MetaView software (Visitron Systems, München, Germany). Immunofluorescence microscopy specimens were analyzed using a confocal scanning microscope (TCS SP-2; Leica Microsystems).
Western Blotting
Total kidney homogenate was produced using sucrose buffer containing 250 mmol/L sucrose, 10 mmol/L triethanolamine, and protease inhibitor cocktail (Complete, Roche Diagnostics) and centrifuged to remove nuclei and cellular debris. Total protein concentration was measured using the Pierce BCA Protein Assay reagent kit (Rockford, IL) and controlled by Coomassie staining. Fifty micrograms of protein was loaded onto 10% to 12% gradient polyacrylamide gels. After SDS-PAGE and electrophoretic transfer of proteins to nitrocellulose membranes, equal protein loading and blotting was verified by membrane staining using Ponceau red. Membranes were probed overnight with antibodies directed against VHL, VEGF, TGF-␤ 1 , ␣-SMA, type 1 collagen, and HO-1, followed by exposure to horseradish-peroxidase-conjugated secondary antibodies (Dako). Immunoreactive bands were detected on the basis of chemiluminescence, using an enhanced chemiluminescence kit (Amersham Biosciences, Buckinghamshire, UK) before exposure to X-ray films (Hyperfilm, Amersham Biosciences). For densitometric evaluation of the resulting bands, films were scanned and analyzed using BIO-PROFIL Bio-1D image software (Vilber Lourmat, Marne-la-Vallée, France).
Morphometry
Damage Scoring
Glomerular and tubulointerstitial damage was determined as described, 16, 18, 19 and assessed on PASstained paraffin sections. A semiquantitative glomerulosclerosis score was established by grading the severity of sclerosis for each glomerulus. Grading was set from 0 to 4 with 0 representing no lesion, 1 representing sclerosis of less than 25% of the glomerulus, and 2, 3, and 4 representing sclerosis of 25% to 50%, 50% to 75%, and more than 75% of the glomerulus, respectively. A whole kidney average sclerosis index was obtained by averaging scores of all glomeruli on one section. On average, 100 to 150 glomeruli were assessed per mouse. The glomerular damage comprised segmental or global collapse of capillaries, with or without associated hyaline deposition, adhesion of the capillary tuft to Bowman's capsule, detachment of podocytes from the GBM, and thickening of mesangial matrix. To assess tubulointerstitial changes a semiquantitative score was established to evaluate the degree and extent of tubulointerstitial damage of each field and was graded from 0 to 4 as follows: 0 represents no lesion, 1 represents tubulointerstitial damage of less than 25% per field, and 2, 3, and 4 represent tubulointerstitial damage of 25% to 50%, 50% to 75%, and more than 75% of the tubulointerstitium, respectively. Approximately 30 cortical and medullary visual fields (20ϫ) per kidney were evaluated. Tubulointerstitial injury was defined by features such as tubular collapse, cast formation with tubular dilatation or atrophy, detachment of cells from the basement membrane, thickening of the tubular basement membrane, number of interstitial cells, and interstitial fibrosis. In ϩDOX increased glomerular and peritubular formation of capillaries without structural alteration of the tubulointerstitium are shown. GN presents the typical features, however, less glomerular and tubulointerstitial injury were encountered in ϩDOX/GN compared with ϪDOX/GN. E and F: Glomerular damage score (E) and tubulointerstitial damage score (F).
‫ء‬ P Ͻ 0.05 for ϪDOX versus ϩDOX; † ber of positive nuclei to the measured tuft area, which was estimated by stereology using image analysis software from MetaView.
Tuft volume was calculated from the mean tuft area by using the following formula: VT ϭ (␤/k)(tuft areas) 3/2 , where ␤ ϭ 1.38 (shape coefficient for spheric particles) and k ϭ 1.1 (size distribution coefficient for spheres). 19 
Glomerular Capillary Density
Semithin plastic sections were stained with Richardson's solution. The area of perfused glomerular capillaries was estimated stereologically on 30 glomeruli per animal. The density of perfused capillaries was calculated by relating the area of perfused capillaries to the measured tuft area.
Tubulointerstitial Capillary Density
Semithin sections were used to estimate the fraction of the tubular circumference that is in close contact to capillaries. Approximately 50 cortical tubules per animal were evaluated stereologically and capillary-epithelial contact areas were calculated for all four grades of tubular degeneration as described by Le Hir and BesseEschmann. 20 
Cellular Proliferation
Cell proliferation was assessed with the Ki-67 antibody technique using paraffin sections. The number of Ki-67-positive endothelial nuclei (as determined by doublelabeling with caveolin) was estimated. Results from numeric evaluation were expressed as the number of labeled glomerular cells per glomeruli or tubulointerstitial cells per visual field (40ϫ). The number of Ki-67-positive epithelial cells were counted and expressed as the number of Ki-67-positive epithelial cells per visual field (40ϫ).
Presentation of Data and Statistical Analysis
Quantitative data are presented as means Ϯ SD. For statistical comparison, the Mann-Whitney U-test was used. P Ͻ 0.05 were considered statistically significant.
Results
Induction of VHL Knockout and GN
Immunohistochemistry of VHL revealed an expression in the proximal tubule with predominance in the convoluted portion. In ϩDOX and ϩDOX/GN, conditional VHL knockout resulted in a strongly reduced tubular epithelial VHL expression ( Figure 1A ) appearing in a mosaic pattern. Western blot analysis of VHL on renal tissue confirmed the kidney targeted deletion of about 65% (see Supplemental Figure S1 at http://ajp.amjpathol.org). Administration of doxycycline resulted in the well-established reduction of target gene degradation as shown by the strong nuclear expression of HIF-1␣ and HIF-2␣ in the ϩDOX groups ( Figure 1 , B and C). As expected, no signal was observed in podocytes. 13 Occasionally, GN induced epithelial HIF-1␣ expression in the distal tubule and HIF-2␣ in single cells of the proximal tubule. In some mice strains, the transition of the parietal epithelial cells toward the proximal tubule occurs in the Bowman's capsule, therefore positive HIF-1␣ and HIF-2␣ signals within the early proximal tubule can be observed in the glomerulus.
Morphologic analysis of glomeruli and the tubulointerstitium did not reveal signs of damage on induction of VHL knockout (Figure 1, D-F) . Both ϪDOX/GN and ϩDOX/GN groups developed crescentic GN with tubulointerstitial disease after injection of the anti-GBM serum. The histopathologic changes were qualitatively identical in both groups but were quantitatively significantly less pronounced in ϩDOX/GN than in ϪDOX/GN. Glomeruli of the ϩDOX/GN displayed less hyaline deposits, sclerotic capillaries, tuft adhesions, and cellular crescent formation. Similarly, tubulointerstitial damage was less pronounced in ϩDOX/GN compared with ϪDOX/GN, showing fewer tubular dilations, cast formations, tubular atrophy, and degeneration.
Next, we correlated the damage scores of glomeruli and tubulointerstitium in ϪDOX/GN and ϩDOX/GN. A strict linear correlation (ϪDOX/GN, r ϭ 0.897; ϩDOX/GN, r ϭ 0.946; both P Ͻ 0.05) with similar correlation coefficients was found in the two groups that were compared.
Administration of doxycycline increased the blood hemoglobin concentration (ϪDOX: 14.7 Ϯ 0.2 g/dL versus ϩDOX: 18.5 Ϯ 1.3 g/dL; P Ͻ 0.05) and hematocrit (ϪDOX: 40.8% Ϯ 1.7% versus ϩDOX: 47.3% Ϯ 3.2%; P Ͻ 0.05) in ϩDOX groups compared with ϪDOX groups. Mice were bled once a week to avoid secondary effects of polycythemia as shown by the time-course of hemoglobin concentration (see Supplemental Table S1 at http://ajp.amjpathol.org). However, renal erythropoietin mRNA concentration was reduced significantly in both ϩDOX and ϩDOX/GN groups (Table 1) . Therefore, we assume that Pax8-driven hepatic erythropoietin production could be responsible for the increased blood hemoglobin concentration and hematocrit. Furthermore, the results foster the idea of an exclusively interstitial source of renal erythropoietin mRNA production. Induction of GN led to strongly increased plasma urea concentration and proteinuria in ϪDOX/GN and ϩDOX/ GN. However, in agreement with the reduced glomerular and tubulointerstitial damage of ϩDOX/GN compared with ϪDOX/GN, plasma urea concentration and urinary protein excretion were less pronounced ( Table 2 ). In addition, the time-course of plasma urea concentration showed a lower augmentation in ϩDOX/GN compared with ϪDOX/GN (see Supplemental Table S1 at http:// ajp.amjpathol.org).
The difference in disease progression may not be related to the humoral immune response to the injected rabbit anti-GBM serum because comparable amounts of mouse anti-rabbit IgG were produced in both GN groups (arbitrary units at OD 450: ϪDOX/GBM 0.48 Ϯ 0.09 and ϩDOX/GBM 0.49 Ϯ 0.12).
Analysis of Capillary Density and Endothelial Cell Proliferation
Morphologic analysis of both ϩDOX and ϩDOX/GN revealed an increase in capillary density. VEGF and PDGF-B are HIF target genes and are important regulators for vascular growth, therefore their mRNA concentration was assessed. Both ϩDOX and ϩDOX/GN showed a significant increase in VEGF mRNA and PDGF-B mRNA levels compared with ϪDOX and ϪDOX/GN (Table 1) .
Then, renal VEGF protein abundance was determined by Western blot analysis and immunohistochemistry. In comparison with ϪDOX, immunohistochemical analysis of VEGF revealed in ϩDOX and ϩDOX/GN a strong augmented expression along the tubule, whereas the podocyte VEGF expression was decreased (Figure 2A) . ϪDOX/GN showed a slight increase in tubular and glomerular VEGF expression levels in animals with low disease score and showed the tendency to be reduced in mice with higher glomerular and tubulointerstitial damage. Immunohistochemical data were confirmed by Western blot analysis ( Figure 2B ). Similarly, in comparison with ϪDOX, serum VEGF levels started to augment continuously by 1 week after administration of doxycycline and/or anti-GBM GN induction. The highest levels of circulating VEGF were observed in both ϩDOX groups ( Figure 2C ; see also Supplemental Table S1 at http:// ajp.amjpathol.org). Next, glomerular and tubulointerstitial endothelial cell proliferation were assessed. In comparison with ϪDOX, in which no glomerular endothelial cell proliferation was found, a strongly increased number of Ki-67-positive endothelial cells per glomeruli was detected in all three groups with the highest amount observed in ϩDOX and ϩDOX/GN (Figure 3, A and B) . Similar results were obtained for the tubulointerstitial endothelial cell proliferation. In ϪDOX only minor tubulointerstitial endothelial cell proliferation was found. A strong increase in the number of Ki-67-positive endothelial cells per visual field were observed in all three groups, again with highest expression levels in ϩDOX and ϩDOX/GN (Figure 3, C and D) .
We then assessed the glomerular capillary density and the tubular-capillary contact. Compared with ϪDOX, glomeruli of ϩDOX showed a significant augmented capillary density (Figure 3 , E and G). Induction of GN strongly reduced the glomerular capillary density but remained higher in ϩDOX/GN compared with ϪDOX/GN. Similar to the glomeruli, the tubular-capillary contact area was higher in ϩDOX than in ϪDOX (Figure 3, F and H) . To analyze whether the grade of the tubular degeneration affects the proportion of the tubular-capillary contact area, stereologic analysis was performed on all four grades of degeneration according to the established description. 20 With increased tubular degeneration the frac- tion of the tubular-capillary contact area continuously decreased in both ϪDOX/GN and ϩDOX/GN, but remained constantly higher in ϩDOX/GN ( Figure 3I ).
Analysis of Interstitial Alterations
VHL knockout was proposed to induce interstitial matrix production. Therefore, the expression levels of TGF-␤ 1 , ␣-SMA, and type 1 collagen were determined. Compared with ϪDOX, TGF-␤ 1 mRNA was increased significantly in all three groups with the highest mRNA expression level in ϩDOX and ϩDOX/GN (Table 1) . TGF-␤ 1 protein expression levels were increased significantly in all three groups compared with ϪDOX. However, the highest abundance was found in both GN groups ( Figure 4A ). In ϪDOX kidneys, immunohistochemical analysis showed only faint TGF-␤ 1 expression in medullary collecting ducts; in ϩDOX kidneys additional interstitial expression was found ( Figure 4D ). Induction of GN strongly augmented TGF-␤ 1 expression in tubular and interstitial cells. Immunohistochemical staining was confirmed by in situ hybridization of TGF-␤ 1 mRNA showing the same expression pattern and changes in intensity levels (not shown). Similar variations in expression levels were obtained for ␣-SMA and type 1 collagen (Figure 4, B and C) . Compared with ϪDOX, kidneys of ϩDOX showed increased interstitial ␣-SMA and type 1 collagen expression (Figure  4, F and G) . Again, the strongest augmentation of both proteins was found after induction of GN in ϪDOX/GN and ϩDOX/GN. 
Analysis of Tubular Epithelial Alterations
To analyze tubular epithelial alterations the renal expression of osteopontin, Ki-67, and HO-1 was determined. ϪDOX kidneys showed osteopontin expression only in medullary collecting ducts ( Figure 6A ), in ϩDOX kidneys an additional cortical distal tubular signal was found. However, strong osteopontin expression was observed along the nephron in ϪDOX/GN and less in ϩDOX/GN. Then, the epithelial proliferation index was determined by counting Ki-67-positive epithelial cells per visual field. Compared with ϪDOX, the number of Ki-67-positive epithelial cells strongly increased in ϩDOX and ϪDOX/GN and the highest proliferation rate was assessed in ϩDOX/GN ( Figure 6B ; respective values are as follows: ϪDOX 1.0 Ϯ 0.2 g/dL; ϩDOX 3.5 Ϯ 1.3 g/dL, P Ͻ 0.05; ϪDOX/GN 3.9 Ϯ 1.9, P Ͻ 0.05; ϩDOX/GN 12.2 Ϯ 1.7, P Ͻ 0.05).
HO-1 expression could not be determined in ϪDOX kidneys. Administration of doxycycline and GN, however, induced its expression in all tubular epithelial cells, with the highest expression levels found in ϩDOX and ϩDOX/GN (Figure 7, A and B) . Renal epithelial expression of HIF-1␣ is well documented, whereas HIF-2␣ was found mainly in renal interstitial fibroblasts and endothelial cells. 21 However, greater nuclear HIF-1␣ and HIF-2␣ stabilization was observed in the pathogenesis of VHL disease with constitutive epithelial expression of both HIF-1␣ and HIF-2␣, 22 confirming the potential of epithelial cells to generate HIF-2␣.
VEGF, a target common to both HIF-1␣ and HIF-2␣, 23 was strongly produced in renal tubules of ϩDOX and ϩDOX/GN, leading to a concomitant fourfold increase in plasma VEGF concentration. As shown in a recent study by Hakroush et al, 19 renal VEGF production is indeed capable in increasing systemic VEGF serum levels, initiating a feedback-mediated decrease in VEGF production by podocytes, which is similar to what we encountered in ϩDOX and ϩDOX/GN. Augmented VEGF levels were reported to induce glomerular changes 19, 24, 25 ; however, glomerular morphology strongly differed between transgenic mice models overexpressing VEGF, which most likely is owing to the varying concentrations of VEGF. Serum VEGF levels increase as a consequence of renal epithelial VHL knockout, leading to glomerular endothelial proliferation associated with capillary growth. 26, 27 Surprisingly, GN induced continuously higher serum VEGF levels over time, albeit with unchanged or diminished expression in the kidney at the end of the animal experiment. A possible explanation could be the timecourse of renal VEGF expression/secretion, which was shown to be increased at the beginning of acute GN and decreased with ongoing disease progression. 28, 29 In VHL knockout mice, the magnitude of GN was reduced and glomerular morphologic alterations were ameliorated, leading to significantly reduced proteinuria and plasma urea concentration. VEGF-induced reduction in glomerular hydrostatic pressure by arteriolar vasodilation 30 and/or increased glomerular surface area available for filtration affecting the filtration coefficient may be responsible. Brenner and colleagues 31 were able to show that chronic moderate anemia, known to induce epithelial HIF-1␣ expression, 32 prevented the development of glomerular hypertension and retarded the progression of structural injury in the deoxycorticosterone acetate-salt model of progressive renal disease. A protective effect of VEGF administration also was observed in the remnant kidney model 33 with increased glomerular capillary density associated with preservation of the glomerular filtration rate. In addition, increased circulating VEGF also may account for the disease amelioration by mediating endothelial cell maintenance and survival. 34 Progressive interstitial fibrosis is associated with the loss of peritubular capillaries, 35 which would be expected to result in chronic ischemia and hypoxia, which, in turn, was assumed to induce endothelial cell apoptosis and therefore to further stimulate the scarring process. 7 In our model, the high VEGF levels induced a strong proliferation of peritubular endothelial cells, showing the capacity to respond to hypoxia similarly as endothelial cells elsewhere. Increased formation of capillaries in both ϩDOX groups led to an augmented fraction of tubular epithelial cells being surrounded by capillaries. The fraction of the tubule-capillary contact area was always significantly higher in ϩDOX/GN compared with ϪDOX/GN. However, both tended to analogously decrease with the grade of tubule degeneration despite maximal HIF-␣ stabilization, VEGF generation, and angiogenesis in ϩDOX/ GN. Moreover, the correlation of the glomerular with the tubulointerstitial damage of ϪDOX/GN and ϩDOX/GN resulted in very similar correlation coefficients. This shows that VHL knockout with presumably improved oxygen supply does not prevent or ameliorate tubular degeneration in this mouse model of GN. We share the concept that the normal tubular epithelium secretes angiogenetic factors for proper oxygen supply, but when degenerating the secretion is diminished and capillaries disappear secondarily. 36 Profibrotic properties of HIF have been described, 9 leading to the hypothesis that hypoxia is not only a result of but also a cause for fibrosis, leading to a vicious circle. VEGF, as a HIF-target gene, was shown to induce TGF-␤ 1 production and secretion in vitro. 37 Recently, transgenic mice overexpressing VEGF in renal epithelia 19 stimulated endothelial cells to produce TGF-␤ 1 and PDGF-B, both cytokines are known to induce the conversion of fibroblasts into myofibroblasts. 38, 39 In our study, VHL knockout induced mild endothelial TGF-␤ 1 and PDGF-B production and enhanced expression of myofibroblasts, as revealed by ␣-SMA-positive interstitial staining associated with increased type 1 collagen synthesis. These results are in agreement with the reduced fibrotic effect in HIF-1␣ knockout mice after ureteral ligation. 9 However, in ϩDOX, renal tubules remained unaffected by the increased interstitial matrix production and renal function persisted at control level during the experiment. Induction of GN induced a strong increase in TGF-␤ 1 and interstitial matrix production assuming that other stronger stimuli than hypoxia may account for the massive fibroblast conversion and collagen production in GN.
For analysis of tubular affections the expression of the adhesion molecule osteopontin and the epithelial proliferation index were determined. Both were associated with tubular damage and fibrosis. The strongest osteopontin expression levels were found after induction of GN, with the highest expression in ϪDOX/GN and to a lesser extent in ϩDOX/GN. This expression pattern showed similar characteristics to the morphologic alterations in both disease groups. Osteopontin induced TGF-␤ 1 production and fibrosis, 40 which is in line with the reduced tubulointerstitial damage score, TGF-␤ 1 , ␣-SMA, and type 1 collagen expression in ϩDOX/GN compared with ϪDOX/GN. An increased number of proliferating tubular cells were observed on VHL knockout and anti-GBM GN, most likely through different mechanisms, as shown by the additive effect obtained in ϩDOX/GN. Recent publications have indicated that limiting cell proliferation could reduce fibrosis development. 41 Furthermore, cell proliferation was shown to be associated with a less-differentiated state, and therefore proliferating cells might be more prone to deposit matrix proteins. On the contrary, HO-1, an HIF target gene and redox-sensitive protein, provides protection from disease. HO-1 is the rate-limiting enzyme involved in the degradation of heme and is known to have cytoprotective effects 6 by the anti-inflammatory, anti-apoptotic, and antiproliferative actions of its end by-products. 42 The role of HO-1 in renal fibrosis was clarified by Kie et al, 43 showing that HO-1 knockout mice had significantly greater tubular TGF-␤ 1 expression, inflammation, and fibrosis after unilateral ureteral obstruction. In our experimental outline HO-1 was expressed most abundantly in all tubular epithelial cells of both ϩDOX and ϩDOX/GN groups compared with a moderate expression pattern in ϪDOX/GN. These results show that induction of HIF-␣ may have damaging and protective impacts on the tubulointerstitium; however, net effects seem to be counterbalanced, as established in our experiment showing the same correlation coefficient between glomerular and tubulointerstitial damage scores.
In conclusion, we can confirm that stabilization of HIFs through VHL knockout has renoprotective effects by ameliorating glomerular disease progression in the anti-GBM GN mouse model, most probably mediated by increased circulating VEGF and associated angiogenesis. However, related to the tubulointerstitium, VHL knockoutinduced effects were balanced within the anti-GBM GN; therefore, neither beneficial nor destructive properties were encountered. Hypoxia with concomitant HIF stabilization thus may be only a mild stimulus for the renal disease progression, and other factors need to be identified for the strong progression observed in anti-GBM GN. In addition, increased tubulointerstitial capillary formation did not halt disease progression. We hypothesize that as long as the tubule functions properly, angiogenetic factors are secreted, establishing the desired oxygen supply. Rarefaction of interstitial capillaries may be secondary to tubule degeneration.
